Clinical trial
Post-marketing Study Assessing the Long-Term Safety of Abatacept
NCT02169544 is registered in ClinicalTrials.gov with Bristol-Myers Squibb as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post-marketing Study Assessing the Long-Term Safety of Abatacept
- Lead sponsor
- Bristol-Myers Squibb
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2014
- Completion date
- February 28, 2017
- Enrollment
- 100,000 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
rheumatoid arthritis